scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/bmcbi/BoLSSYW06 |
P6179 | Dimensions Publication ID | 1032389976 |
P356 | DOI | 10.1186/1471-2105-7-122 |
P932 | PMC publication ID | 1421440 |
P698 | PubMed publication ID | 16526963 |
P5875 | ResearchGate publication ID | 7251314 |
P50 | author | Wenjie Shu | Q54937138 |
Xiaochen Bo | Q89462087 | ||
P2093 | author name string | Jing Yang | |
Shengqi Wang | |||
Daochun Sun | |||
Shaoke Lou | |||
P2860 | cites work | Efficient algorithms for folding and comparing nucleic acid sequences | Q40492309 |
An overview of progress in antisense therapeutics | Q40858877 | ||
A bayesian statistical algorithm for RNA secondary structure prediction | Q42605599 | ||
Implication of RNA structure on antisense oligonucleotide hybridization kinetics | Q45059437 | ||
Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. | Q45773186 | ||
Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming. | Q45966750 | ||
Computational antisense oligo prediction with a neural network model | Q48268825 | ||
Prediction of RNA base pairing probabilities on massively parallel computers. | Q52076594 | ||
Training feedforward networks with the Marquardt algorithm. | Q52219242 | ||
Using RNAFOLD to predict the activity of small catalytic RNAs. | Q52221221 | ||
Complete suboptimal folding of RNA and the stability of secondary structures. | Q52222269 | ||
Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides | Q72211702 | ||
Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding | Q72358554 | ||
ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides | Q73275675 | ||
Computational approaches to the identification of ribozyme target sites | Q73469200 | ||
Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries | Q74109346 | ||
Concepts to automate the theoretical design of effective antisense oligonucleotides | Q77296272 | ||
Prediction of antisense oligonucleotide efficacy by in vitro methods | Q77683916 | ||
Mfold web server for nucleic acid folding and hybridization prediction | Q24498105 | ||
Predicting oligonucleotide affinity to nucleic acid targets | Q24539440 | ||
Using an RNA secondary structure partition function to determine confidence in base pairs predicted by free energy minimization | Q24540294 | ||
Sfold web server for statistical folding and rational design of nucleic acids | Q24562042 | ||
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information | Q24602467 | ||
Profiled support vector machines for antisense oligonucleotide efficacy prediction | Q24792682 | ||
Vienna RNA secondary structure server | Q28131816 | ||
Selecting effective antisense reagents on combinatorial oligonucleotide arrays | Q28240424 | ||
The equilibrium partition function and base pair binding probabilities for RNA secondary structure | Q28261689 | ||
The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
On finding all suboptimal foldings of an RNA molecule | Q29547627 | ||
Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. | Q30662658 | ||
mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides | Q30961001 | ||
Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination | Q33771816 | ||
RNA secondary structure: physical and computational aspects | Q33934096 | ||
Selecting optimal antisense reagents | Q34062626 | ||
Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA | Q34179717 | ||
Antisense therapeutics: lessons from early clinical trials | Q34416864 | ||
A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures | Q34646063 | ||
Approaches for the sequence-specific knockdown of mRNA. | Q35597089 | ||
Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond | Q38303734 | ||
Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. | Q38304416 | ||
RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts | Q38311071 | ||
Effects of RNA secondary structure on cellular antisense activity | Q38315200 | ||
Artificial neural network prediction of antisense oligodeoxynucleotide activity | Q38362285 | ||
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability | Q39729504 | ||
Thermodynamic criteria for high hit rate antisense oligonucleotide design | Q39959025 | ||
Computation of statistical secondary structure of nucleic acids | Q40466347 | ||
P304 | page(s) | 122 | |
P577 | publication date | 2006-03-09 | |
P1433 | published in | BMC Bioinformatics | Q4835939 |
P1476 | title | Selection of antisense oligonucleotides based on multiple predicted target mRNA structures | |
P478 | volume | 7 |
Q36740097 | Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design |
Q33287053 | Identification of sequence motifs significantly associated with antisense activity |
Q39001868 | In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide |
Q55394821 | In vitro inhibition of porcine reproductive and respiratory syndrome virus replication by short antisense oligonucleotides with locked nucleic acid modification. |
Q35743375 | Inhibition of porcine reproductive and respiratory syndrome virus replication in vitro using DNA-based short antisense oligonucleotides |
Search more.